SCREENER COMPARE ANY 2 STOCKS

EARNINGS CALL ARCHIVE 4 CALLS ON FILE

HBIO — Harvard Bioscience, Inc.

NASDAQ

FULL STOCK PAGE →

Q2 2026 Earnings Call Summary

AUG 11, 2026

REVENUE

$22.7M +9.5%

NET MARGIN

-12.8% +3.7 PTS

EPS

-$0.64 +16.9%

FREE CASH FLOW

-$365000 +66.5%

No summary has been written for this call yet.